0310-0569 : Lynparza 100 mg Oral Tablet, Film Coated
| NDC: | 0310-0569 |
| Labeler: | Astrazeneca Pharmaceuticals Lp |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Lynparza |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | NDA208558 |
| Rev. Date: |
NDC Package Codes:
- 0310-0569-12: 120 TABLET, FILM COATED IN 1 BOTTLE (0310‑0569‑12)
- 0310-0569-60: 60 TABLET, FILM COATED IN 1 BOTTLE, PLASTIC (0310‑0569‑60)
Active Ingredients:
- Olaparib
Dosage Strength:
- 100 mg
Pharmaceutical Classes:
- Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
- Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0310-0578 Lynparza 150 mg Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp
- 0310-0657 Lynparza 50 mg Oral Capsule by Astrazeneca Pharmaceuticals Lp
- 0310-0668 Lynparza 100 mg Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp
- 0310-0679 Lynparza 150 mg Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0310-0512Next: 0310-0578 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.